Format

Send to

Choose Destination
J Immunol. 2017 Jul 1;199(1):27-32. doi: 10.4049/jimmunol.1601062. Epub 2017 May 26.

Cutting Edge: Origins, Recruitment, and Regulation of CD11c+ Cells in Inflamed Islets of Autoimmune Diabetes Mice.

Author information

1
Department of Surgery, University of California, San Francisco, San Francisco, CA 94143.
2
Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305; and.
3
Department of Pathology and Immunology, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO 63110.
4
Department of Surgery, University of California, San Francisco, San Francisco, CA 94143; Qizhi.Tang@ucsf.edu.

Abstract

In NOD mice, CD11c+ cells increase greatly with islet inflammation and contribute to autoimmune destruction of pancreatic β cells. In this study, we investigated their origin and mechanism of recruitment. CD11c+ cells in inflamed islets resembled classical dendritic cells based on their transcriptional profile. However, the majority of these cells were not from the Zbtb46-dependent dendritic-cell lineage. Instead, monocyte precursors could give rise to CD11c+ cells in inflamed islets. Chemokines Ccl5 and Ccl8 were persistently elevated in inflamed islets and the influx of CD11c+ cells was partially dependent on their receptor Ccr5. Treatment with islet Ag-specific regulatory T cells led to a marked decrease of Ccl5 and Ccl8, and a reduction of monocyte recruitment. These results implicate a monocytic origin of CD11c+ cells in inflamed islets and suggest that therapeutic regulatory T cells directly or indirectly regulate their influx by altering the chemotactic milieu in the islets.

PMID:
28550204
PMCID:
PMC5501182
DOI:
10.4049/jimmunol.1601062
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center